Revance Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/13/2025

Shares

49,373

Value ($000)

150

Weight

0.0%

2019 Q4 - 2024 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/13/2025	150	0.0%	49,373	12/31/2024
2024 Q3	11/13/2024	201	0.0%	38,698	9/30/2024
2024 Q2	8/13/2024	162	0.0%	62,930	6/30/2024
2024 Q1	5/10/2024	271	0.0%	55,073	3/31/2024
2023 Q4	2/9/2024	336	0.0%	38,279	12/31/2023
2023 Q3	11/13/2023	405	0.0%	35,333	9/30/2023
2023 Q2	8/15/2023	1,822	0.0%	72,007	6/30/2023
2023 Q1	5/12/2023	1,740	0.0%	54,017	3/31/2023
2022 Q4	2/13/2023	1,555	0.0%	84,237	12/31/2022
2022 Q3	11/14/2022	2,498	0.0%	92,505	9/30/2022
2022 Q2	8/12/2022	1,277	0.0%	92,337	6/30/2022
2022 Q1	5/16/2022	2,017	0.0%	103,430	3/31/2022
2021 Q4	2/14/2022	2,779	0.0%	170,239	12/31/2021
2021 Q3	11/15/2021	13,746	0.0%	493,384	9/30/2021
2021 Q2	8/16/2021	12,064	0.0%	407,009	6/30/2021
2021 Q1	5/13/2021	11,751	0.0%	420,382	3/31/2021
2020 Q4	2/9/2021	12,180	0.0%	429,800	12/31/2020
2020 Q3	11/5/2020	6,335	0.0%	251,993	9/30/2020
2020 Q2	8/13/2020	1,898	0.0%	77,727	6/30/2020
2020 Q1	5/14/2020	837	0.0%	56,576	3/31/2020
2019 Q4	2/14/2020	728	0.0%	44,902	12/31/2019